Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

ClinicalTrials.gov ID: NCT00499720

Public ClinicalTrials.gov record NCT00499720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Expanded Access Program for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Who Have Limited Treatment Options and Are at Risk for Disease Progression

Study identification

NCT ID
NCT00499720
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Gilead Sciences
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Aztreonam Lysine for Inhalation Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 1, 2011

United States locations

U.S. sites
64
U.S. states
32
U.S. cities
56
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233
Not listed Anchorage Alaska 99508
Not listed Phoenix Arizona 85016
Not listed Little Rock Arkansas 72205
Not listed Los Angeles California 90027
Not listed Sacramento California 95819
Not listed San Francisco California 94115
Not listed San Francisco California 94143
Not listed Denver Colorado 80045
Not listed Denver Colorado 80206
Not listed Hartford Connecticut 06102
Not listed Hartford Connecticut 06106
Not listed Ft, Meyers Florida 33908
Not listed Gainesville Florida 32610
Not listed Orlando Florida 32803
Not listed St. Petersburg Florida 33701
Not listed Tampa Florida 33606
Not listed Boise Idaho 83712
Not listed Chicago Illinois 60302
Not listed Chicago Illinois 60614
Not listed Maywood Illinois 60153
Not listed Des Moines Iowa 50309
Not listed Wichita Kansas 67214
Not listed New Orleans Louisiana 70112
Not listed Boston Massachusetts 02111
Not listed Boston Massachusetts 02114
Not listed Detroit Michigan 48201
Not listed Minneapolis Minnesota 54404
Not listed Minneapolis Minnesota 55455
Not listed Columbia Missouri 65212
Not listed Kansas City Missouri 64108
Not listed Great Falls Montana 59405
Not listed Las Vegas Nevada 89107
Not listed Long Branch New Jersey 07740
Not listed New Brunswick New Jersey 08901
Not listed Albuquerque New Mexico 87131
Not listed Albany New York 12208-3479
Not listed Buffalo New York 14222
Not listed New Hyde Park New York 11040
Not listed New York New York 10011
Not listed New York New York 10032
Not listed Syracuse New York 13210
Not listed Valhalla New York 10595
Not listed Chapel Hill North Carolina 27599-7220
Not listed Akron Ohio 44308
Not listed Cincinnati Ohio 45229
Not listed Cleveland Ohio 44106
Not listed Columbus Ohio 43205
Not listed Toledo Ohio 43605
Not listed Oklahoma City Oklahoma 73104
Not listed Hershey Pennsylvania 17033
Not listed Philadelphia Pennsylvania 19104
Not listed Philadelphia Pennsylvania 19134
Not listed Pittsburgh Pennsylvania 15213
Not listed Sioux Falls South Dakota 57117
Not listed Memphis Tennessee 38103
Not listed Dallas Texas 75230
Not listed Fort Worth Texas 76104
Not listed San Antonio Texas 78212
Not listed Salt Lake City Utah 84132-4701
Not listed Norfolk Virginia 23507
Not listed Portsmouth Virginia 23708
Not listed Richmond Virginia 23219
Not listed Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00499720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00499720 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →